Genuine Latisse - $49 each when you buy 2

Latisse Faces Patent Challenge

July 13, 2010 · Posted in Daily Health News 

The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version. (Source: WSJ.com: Health)

Read more from the original source:
Latisse Faces Patent Challenge

Comments

Leave a Reply




*